iifl-logo-icon 1

Nath Bio-Genes (India) Ltd Board Meeting

177.29
(1.94%)
Jan 14, 2025|02:44:55 PM

Nath Bio-Genes CORPORATE ACTIONS

15/01/2024calendar-icon
14/01/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting23 Oct 202417 Oct 2024
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve unaudited financial results for the quarter and half year ended 30th September 2024. Outcome of Board Meeting (As Per BSE Announcement Dated on: 23/10/2024)
Board Meeting7 Aug 202430 Jul 2024
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve Unaudited financial results as on 30th June 2024. Unaudited financial results as at 30th June 2024. (As Per BSE Announcement dated on 07.08.2024)
Board Meeting8 May 202430 Apr 2024
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve Audited Financial Results for the year ended 31st March 2024. Outcome of Board meeting held on 08th May 2024 for approval of 1. Audited Financial Results as on 31st March 2024. 2. Recommendation of Dividend by Board of Directors 3. Date of Annual General Meeting of the Company for financial year 2023-24 Outcome of Board Meeting of the Company held on 08th May 2024. Outcome of Board meeting held on 08th May 2024 for approval of 1. Audited Financial Results as on 31st March 2024. 2. Recommendation of Dividend by Board of Directors 3. Date of Annual General Meeting of the Company for financial year 2023-24 (As Per BSE Announcement Dated on 08.05.2024)
Board Meeting18 Jan 20249 Jan 2024
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/01/2024 inter alia to consider and approve Unaudited Financial Results as of 31st December 2023. Outcome of Board Meeting (As Per BSE Announcement Dated on 18/01/2024)

Nath Bio-Genes: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.